PET-CT in the Organ Transplantation
Publisher
Springer Singapore
Reference32 articles.
1. Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH. Predictive value of 18F-FDG PET/CT for vascular invasion in patients with hepatocellular carcinoma before liver transplantation. Clin Nucl Med. 2017;42:e183–7. https://doi.org/10.1097/RLU.0000000000001545.
2. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet. 1999;353(9158):1083–91.
3. Apel H, Walschburger-Zorn K, Haberle L, Wach S, Engehausen DG, Wullich B. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr. Clin Transpl. 2013;27(1):E30–6.
4. Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation. 2004;77(12):1777–82.
5. Li J, Liu Y, Wang Z. Multimodality imaging features, treatment, and prognosis of post-transplant lymphoproliferative disorder in renal allografts. Medicine (Baltimore). 2018;97(17):e0531.